SE368576B - - Google Patents

Info

Publication number
SE368576B
SE368576B SE05909/69A SE590969A SE368576B SE 368576 B SE368576 B SE 368576B SE 05909/69 A SE05909/69 A SE 05909/69A SE 590969 A SE590969 A SE 590969A SE 368576 B SE368576 B SE 368576B
Authority
SE
Sweden
Application number
SE05909/69A
Inventor
K Harsanyi
J Reiter
D Korbonits
C Gonczi
K Taktacs
E Bako
G Leszkovsky
L Tardos
C Vertesi
Original Assignee
Chinoin Gyogyszer Es Vegyeszet
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chinoin Gyogyszer Es Vegyeszet filed Critical Chinoin Gyogyszer Es Vegyeszet
Publication of SE368576B publication Critical patent/SE368576B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D271/00—Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms
    • C07D271/02—Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms not condensed with other rings
    • C07D271/06—1,2,4-Oxadiazoles; Hydrogenated 1,2,4-oxadiazoles

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
SE05909/69A 1968-04-26 1969-04-25 SE368576B (cs)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
HUCI000796 1968-04-26

Publications (1)

Publication Number Publication Date
SE368576B true SE368576B (cs) 1974-07-08

Family

ID=10994349

Family Applications (1)

Application Number Title Priority Date Filing Date
SE05909/69A SE368576B (cs) 1968-04-26 1969-04-25

Country Status (15)

Country Link
US (1) US3647809A (cs)
JP (1) JPS4824394B1 (cs)
AT (2) AT292728B (cs)
BE (1) BE732131A (cs)
BR (1) BR6908381D0 (cs)
CA (1) CA954858A (cs)
CH (2) CH540925A (cs)
DE (1) DE1920037A1 (cs)
FR (1) FR2007529B1 (cs)
GB (1) GB1271302A (cs)
IL (1) IL31990A (cs)
NL (1) NL6906401A (cs)
NO (1) NO124253B (cs)
PL (1) PL79435B1 (cs)
SE (1) SE368576B (cs)

Families Citing this family (39)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3853893A (en) * 1973-04-02 1974-12-10 Squibb & Sons Inc Anthelmintic 5-(pyridyl)-3-(isothiocyanophenyl) oxadiazoles
HU177086B (en) * 1975-06-09 1981-07-28 Eszakmagyar Vegyimuevek Herbicide and fungicide preparation containing substituted 1,2,4-oxadiazolidin-3-one derivatives
JPS58150576A (ja) * 1982-03-03 1983-09-07 Sumitomo Chem Co Ltd 新規な１，２，４−オキサジアゾ−ル誘導体
DE3247118A1 (de) * 1982-12-20 1984-06-20 Cassella Ag, 6000 Frankfurt Neue substituierte 1,4-dihydropyridine, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel
EP1582519A3 (en) * 1999-08-19 2005-12-21 Nps Pharmaceuticals, Inc. Heteropolycyclic compounds and their use as metabotropic glutamate receptor antagonists
DK1210344T3 (da) * 1999-08-19 2006-03-06 Nps Pharma Inc Heteropolycykliske forbindelser og anvendelser deraf som metabotrope glutamatreceptorantagonister
US6660753B2 (en) * 1999-08-19 2003-12-09 Nps Pharmaceuticals, Inc. Heteropolycyclic compounds and their use as metabotropic glutamate receptor antagonists
PL369598A1 (en) * 2001-02-21 2005-05-02 Nps Pharmaceuticals, Inc. Heteropolycyclic compounds and their use as metabotropic glutamate receptor antagonists
WO2004014902A2 (en) * 2002-08-09 2004-02-19 Astrazeneca Ab Compounds having an activity at metabotropic glutamate receptors
EP1611123B8 (en) * 2003-04-09 2013-11-13 Exelixis, Inc. Tie-2 modulators and methods of use
AU2004240586A1 (en) * 2003-05-15 2004-12-02 Merck & Co., Inc. 3-(2-amino-1-azacyclyl)-5-aryl-1,2,4-oxadiazoles as S1P receptor agonists
US20060189661A1 (en) * 2003-11-03 2006-08-24 Wagenen Bradford V Heteropolycyclic compounds and their use as metabotropic glutamate receptor antagonists
WO2005060961A2 (en) * 2003-12-18 2005-07-07 Astrazeneca Ab Treatment of transient lower esophageal sphincter relaxations (tlesrs) and gastro-esophageal reflux disease (gerd)
CN1898235A (zh) * 2003-12-24 2007-01-17 普罗西迪恩有限公司 作为gpcr受体激动剂的杂环衍生物
WO2005077368A2 (en) * 2004-02-03 2005-08-25 Astrazeneca Ab Treatment of gastro-esophageal reflux disease (gerd)
CA2606087A1 (en) 2005-04-26 2006-11-02 Neurosearch A/S Novel oxadiazole derivatives and their medical use
IL169855A (en) * 2005-07-25 2014-05-28 Elta Systems Ltd A system and method for locating a receiver location
EP1907382B1 (en) 2005-07-26 2015-05-27 Bial-Portela & CA, S.A. Nitrocatechol derivatives as comt inhibitors
EP1845097A1 (en) 2006-04-10 2007-10-17 Portela & Ca., S.A. Oxadiazole derivatives as COMT inhibitors
CL2007002593A1 (es) * 2006-09-07 2008-06-13 Actelion Pharmaceuticals Ltd Compuestos derivados de 4-heteroaril-piridina; composicion farmaceutica; y uso en el tratamiento de enfermedades tales como rechazo de organos transplantados, sindromes autoinmunes y cancer.
KR101454937B1 (ko) * 2006-09-08 2014-10-27 액테리온 파마슈티칼 리미티드 면역조절제로서 피리딘-3-일 유도체
PT2124947T (pt) * 2007-01-31 2017-10-25 BIAL-PORTELA & Cª S A Regime posológico para inibidores da comt
PL2125797T3 (pl) * 2007-03-16 2014-06-30 Actelion Pharmaceuticals Ltd Pochodne aminopirydyny jako agoniści receptora S1P1/EDG1
CN102648198B (zh) * 2007-08-17 2015-04-01 埃科特莱茵药品有限公司 作为s1p1/edg1受体调节剂的吡啶衍生物
CN101959504A (zh) * 2008-02-28 2011-01-26 比艾尔-坡特拉有限公司 用于难溶性药物的药物组合物
ES2389042T3 (es) * 2008-03-06 2012-10-22 Actelion Pharmaceuticals Ltd. Compuestos de piridina
US8575200B2 (en) * 2008-03-07 2013-11-05 Actelion Pharmaceuticals Ltd Pyridin-2-yl derivatives as immunomodulating agents
BRPI0908731A2 (pt) 2008-03-17 2017-05-16 Bial - Portela & C A S A formas cristalinas de 5-[3-(2,5-dicloro-4,6-dimetil-1-óxi-piridina-3-il)[1,2,4]oxadiazol-5-il]-3-nitrobenzeno-1,2-diol
EP2291080B1 (en) * 2008-05-14 2015-08-19 The Scripps Research Institute Novel modulators of sphingosine phosphate receptors
HUE046023T2 (hu) 2009-02-10 2020-01-28 Monsanto Technology Llc Készítmények és eljárások nematódák irtására
ES2730678T3 (es) 2009-04-01 2019-11-12 Bial Portela & Ca Sa Formulaciones farmacéuticas que comprenden derivados de nitrocatecol y métodos para fabricarlas
AU2010231962B2 (en) * 2009-04-01 2015-05-21 Bial - Portela & Ca., S.A. Pharmaceutical formulations comprising nitrocatechol derivatives and methods of making the same
DK2454255T3 (da) 2009-07-16 2013-12-16 Actelion Pharmaceuticals Ltd Pyridin-4-ylderivater som s1p1/edg1-agonister
SG191742A1 (en) 2011-01-19 2013-08-30 Actelion Pharmaceuticals Ltd 2-methoxy-pyridin-4-yl derivatives
US20140045900A1 (en) 2011-02-11 2014-02-13 Bial-Portela & Ca, S.A. Administration regime for nitrocatechols
WO2013089573A1 (en) 2011-12-13 2013-06-20 BIAL - PORTELA & Cª., S.A. Chemical compound useful as intermediate for preparing a catechol-o-methyltransferase inhibitor
UA114748C2 (uk) * 2013-02-15 2017-07-25 Монсанто Текнолоджи Ллс 3,5-дизаміщені-4,5-дигідро-1,2,4-оксадіазоли для боротьби з нематодними шкідниками
JP2018500300A (ja) 2014-11-28 2018-01-11 ノヴィファーマ，エス．アー． パーキンソン病を遅延させるための医薬
CA2981130C (en) 2015-05-20 2021-06-01 Cyrille Lescop Crystalline form of the compound (s)-3-{4-[5-(2-cyclopentyl-6-methoxy-pyridin-4-yl)-[1,2,4]oxadiazol-3-yl]-2-ethyl-6-methyl-phenoxy}-propane-1,2-diol

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL120029C (cs) * 1959-09-29
US3227725A (en) * 1962-04-17 1966-01-04 Union Carbide Corp Certain 3,5-disubstituted 1,2,4-oxadiazole compounds

Also Published As

Publication number Publication date
GB1271302A (en) 1972-04-19
DE1920037A1 (de) 1970-11-12
FR2007529A1 (cs) 1970-01-09
AT292728B (de) 1971-09-10
BR6908381D0 (pt) 1973-02-08
US3647809A (en) 1972-03-07
FR2007529B1 (cs) 1973-03-16
CH540925A (de) 1973-08-31
BE732131A (cs) 1969-10-01
JPS4824394B1 (cs) 1973-07-20
IL31990A0 (en) 1969-06-25
CH542232A (de) 1973-11-15
AT292727B (de) 1971-09-10
NO124253B (cs) 1972-03-27
CA954858A (en) 1974-09-17
NL6906401A (cs) 1969-10-28
IL31990A (en) 1974-05-16
PL79435B1 (en) 1975-06-30

Similar Documents

Publication Publication Date Title
AU428130B2 (cs)
AU2374870A (cs)
AU5184069A (cs)
AU6168869A (cs)
AU6171569A (cs)
AU429879B2 (cs)
AU416157B2 (cs)
AU2581067A (cs)
AU4811568A (cs)
AU421558B1 (cs)
AU3789668A (cs)
AU4744468A (cs)
AU3224368A (cs)
AU2580267A (cs)
AU479393A (cs)
BE708888A (cs)
AU4503667A (cs)
AU4558658A (cs)
AU463027A (cs)
AU4270368A (cs)
BE722218A (cs)
AU479894A (cs)
AU4224469A (cs)
AU3083868A (cs)
AU2889368A (cs)